본문 바로가기
KERD
논문KCI 등재

Health Effects of Chronic Arsenic Exposure

1

조회

0

다운로드

5

인용

0

참고문헌

키워드

초록

Arsenic is a unique element with distinct physical characteristics and toxicity whose importance in public health is well recognized. The toxicity of arsenic varies across its different forms. While the carcinogenicity of arsenic has been confirmed, the mechanisms behind the diseases occurring after acute or chronic exposure to arsenic are not well understood. Inorganic arsenic has been confirmed as a human carcinogen that can induce skin, lung, and bladder cancer. There are also reports of its significant association to liver, prostate, and bladdercancer. Recent studies have also suggested a relationship with diabetes, neurological effects, cardiac disorders, and reproductive organs,but further studies are required to confirm these associations. The majority of research to date has examined cancer incidence aftera high exposure to high concentrations of arsenic. However, numerous studies have reported various health effects caused by chronicexposure to low concentrations of arsenic. An assessment of the health effects to arsenic exposure has never been performed in the South Korean population; thus, objective estimates of exposure levels are needed. Data should be collected on the biological exposure level for the total arsenic concentration, and individual arsenic concentration by species. In South Korea, we believe that biological exposureassessment should be the first step, followed by regular health effect assessments.

Abstract

Arsenic is a unique element with distinct physical characteristics and toxicity whose importance in public health is well recognized. The toxicity of arsenic varies across its different forms. While the carcinogenicity of arsenic has been confirmed, the mechanisms behind the diseases occurring after acute or chronic exposure to arsenic are not well understood. Inorganic arsenic has been confirmed as a human carcinogen that can induce skin, lung, and bladder cancer. There are also reports of its significant association to liver, prostate, and bladdercancer. Recent studies have also suggested a relationship with diabetes, neurological effects, cardiac disorders, and reproductive organs,but further studies are required to confirm these associations. The majority of research to date has examined cancer incidence aftera high exposure to high concentrations of arsenic. However, numerous studies have reported various health effects caused by chronicexposure to low concentrations of arsenic. An assessment of the health effects to arsenic exposure has never been performed in the South Korean population; thus, objective estimates of exposure levels are needed. Data should be collected on the biological exposure level for the total arsenic concentration, and individual arsenic concentration by species. In South Korea, we believe that biological exposureassessment should be the first step, followed by regular health effect assessments.

참고문헌 (60)

  1. "Toxicological profile for arsenic; 2007"[URL]
  2. Tchounwou PB, "Important considerations in the development of public health advisories for arsenic and arsenic-containing compounds in drinking water", Rev Environ Health, 14(4), pp.211~229 (1999)
  3. Rousselot P, "Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients", Cancer Res, 59(5), pp.1041~1048 (1999)
  4. Mandal BK, "Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India", Chem Res Toxicol, 14(4), pp.371~378 (2001)
  5. "IARC monographs on the evaluation of carcinogen risks to humans" (2004)[URL]
  6. "An exposure and risk assessment for arsenic" (1982)[URL]
  7. Marchiset-Ferlay N, "What is the best biomarker to assess arsenic exposure via drinking water?", Environ Int, 39(1), pp.150~171 (2012)
  8. Cho Y, "Association of arsenic levels in soil and water with urinary arsenic concentration of residents in the vicinity of closed metal mines", Int J Hyg Environ Health, 216(3), pp.255~262 (2013)
  9. Hanlon DP, "Placental permeability of arsenate ion during early embryogenesis in the hamster", Experientia, 33(9), pp.1221~1222 (1977)
  10. Tchounwou PB, "Carcinogenic and systemic health effects associated with arsenic exposure: a critical review", Toxicol Pathol, 31(6), pp.575~588 (2003)
  11. Buchet JP, "Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers", Int Arch Occup Environ Health, 48(2), pp.111~118 (1981)
  12. Centeno JA, "Metal contaminants in New Zealand: sources, treatments, and effects on ecology and human health", pp.195~219 (2005), Resolutionz Press
  13. Abernathy CO, "Arsenic: health effects, mechanisms of actions, and research issues", Environ Health Perspect, 107(7), pp.593~597 (1999)
  14. Goyer RA, "Casarett and Doull’s toxicology: the basic science of poisons", pp.811~867 (2001), McGraw-Hill
  15. Hughes MF, "Arsenic toxicity and potential mechanisms of action", Toxicol Lett, 133(1), pp.1~16 (2002)
  16. Centeno JA, "Managing arsenic in the environment: from soil to human health", pp.311~327 (2006), CSIRO Publishing
  17. "Arsenic and arsenic compounds", IARC Monogr Eval Carcinog Risk Chem Hum, 23, pp.39~141 (1980)
  18. Kapaj S, "Human health effects from chronic arsenic poisoning: a review", J Environ Sci Health A Tox Hazard Subst Environ Eng, 41(10), pp.2399~2428 (2006)
  19. Chen CJ, "Arsenic and cancers", Lancet, 1(8582), pp.414~415 (1988)
  20. Kurokawa M, "Investigation of skin manifestations of arsenicism due to intake of arsenic-contaminated groundwater in residents of Samta, Jessore, Bangladesh", Arch Dermatol, 137(1), pp.102~103 (2001)
  21. Smith AH, "Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water", Am J Epidemiol, 147(7), pp.660~669 (1998)
  22. Hopenhayn-Rich C, "Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina", Int J Epidemiol, 27(4), pp.561~569 (1998)
  23. Rossman TG, "Evidence that arsenite acts as a cocarcinogen in skin cancer", Toxicol Appl Pharmacol, 198(3), pp.394~404 (2004)
  24. Hsueh YM, "Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer", Cancer Epidemiol Biomarkers Prev, 6(8), pp.589~596 (1997)
  25. Luster MI, "Arsenic and urinary bladder cell proliferation", Toxicol Appl Pharmacol, 198(3), pp.419~423 (2004)
  26. Leonardi G, "Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study", Environ Health Perspect, 120(5), pp.721~726 (2012)
  27. Ferreccio C, "Lung cancer and arsenic concentrations in drinking water in Chile", Epidemiology, 11(6), pp.673~679 (2000)
  28. Smith AH, "Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood", Environ Health Perspect, 114(8), pp.1293~1296 (2006)
  29. Chiou HY, "Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan", Cancer Res, 55(6), pp.1296~1300 (1995)
  30. Chiu HF, "Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in Southwestern Taiwan", Lung Cancer, 46(3), pp.265~270 (2004)
  31. Chen CL, "Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan", JAMA, 292(24), pp.2984~2990 (2004)
  32. Garcia-Esquinas E, "Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study", Cancer Epidemiol Biomarkers Prev, 22(11), pp.1944~1953 (2013)
  33. Chiang HS, "The incidence of bladder cancer in the black foot disease endemic area in Taiwan", Br J Urol, 71(3), pp.274~278 (1993)
  34. Gabriel HE, "Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults", Am J Clin Nutr, 83(4), pp.835~841 (2006)
  35. Gamble MV, "Folic acid supplementation lowers blood arsenic", Am J Clin Nutr, 86(4), pp.1202~1209 (2007)
  36. Meliker JR, "Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA", Cancer Causes Control, 21(5), pp.745~757 (2010)
  37. Morales KH, "Risk of internal cancers from arsenic in drinking water", Environ Health Perspect, 108(7), pp.655~661 (2000)
  38. Baastrup R, "Arsenic in drinking-water and risk for cancer in Denmark", Environ Health Perspect, 116(2), pp.231~237 (2008)
  39. Lin HJ, "Arsenic levels in drinking water and mortality of liver cancer in Taiwan", J Hazard Mater, 262, pp.1132~1138 (2013)
  40. Durant JL, "Elevated incidence of childhood leukemia in Woburn, Massachusetts: NIEHS Superfund Basic Research Program searches for causes", Environ Health Perspect, 103(6), pp.93~98 (1995)
  41. Heck JE, "Risk of leukemia in relation to exposure to ambient air toxics in pregnancy and early childhood", Int J Hyg Environ Health, 217(6), pp.662~668 (2014)
  42. Tsai SY, "The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence", Neurotoxicology, 24(4-5), pp.747~753 (2003)
  43. Wasserman GA, "Water arsenic exposure and children’s intellectual function in Araihazar, Bangladesh", Environ Health Perspect, 112(13), pp.1329~1333 (2004)
  44. Lai MS, "Ingested inorganic arsenic and prevalence of diabetes mellitus", Am J Epidemiol, 139(5), pp.484~492 (1994)
  45. Tseng CH, "Epidemiologic evidence of diabetogenic effect of arsenic", Toxicol Lett, 133(1), pp.69~76 (2002)
  46. Nizam S, "Differences in urinary arsenic metabolites between diabetic and non-diabetic subjects in Bangladesh", Int J Environ Res Public Health, 10(3), pp.1006~1019 (2013)
  47. Ahsan H, "Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh", J Occup Environ Med, 42(12), pp.1195~1201 (2000)
  48. Ahsan H, "Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh : baseline results from the Health Effects of Arsenic Longitudinal Study", Am J Epidemiol, 163(12), pp.1138~1148 (2006)
  49. Lee MY, "Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease", wToxicol Appl Pharmacol, 179(2), pp.83~88 (2002)
  50. Chakraborti D, "Arsenic groundwater contamination in Middle Ganga Plain, Bihar, India: a future danger?", Environ Health Perspect, 111(9), pp.1194~1201 (2003)
  51. Hopenhayn C, "Profile of urinary arsenic metabolites during pregnancy", Environ Health Perspect, 111(16), pp.1888~1891 (2003)
  52. Chattopadhyay S, "Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants", Toxicol Lett, 136(1), pp.65~76 (2002)
  53. Hopenhayn C, "Arsenic exposure from drinking water and birth weight", Epidemiology, 14(5), pp.593~602 (2003)
  54. Kile ML, "Variability in biomarkers of arsenic exposure and metabolism in adults over time", Environ Health Perspect, 117(3), pp.455~460 (2009)
  55. Loffredo CA, "Variability in human metabolism of arsenic", Environ Res, 92(2), pp.85~91 (2003)
  56. Jung-Duck Park, "Urinary Arsenic Concentrations and their Associated Factors in Korean Adults", 한국독성학회지, 29(2), pp.137~142 (2013), 한국독성학회[DOI]
  57. Eom SY, "Effects of low-level arsenic exposure on urinary N-acetyl-β-D-glucosa-minidase activity", Hum Exp Toxicol, 30(12), pp.1885~1891 (2011)
  58. in urine of children compared to adults from an arsenic exposed area in Bangladesh, "J Environ Sci Health A Tox Hazard Subst Environ Eng", 2003, 87~113
  59. Wen W, "Metabolites of arsenic and increased DNA damage of p53 gene in arsenic plant workers", Toxicol Appl Pharmacol, 254(1), pp.41~47 (2011)
  60. Hsueh YM, "Urinary arsenic species and CKD in a Taiwanese population: a case-control study", Am J Kidney Dis, 54(5), pp.859~870 (2009)

관련 논문AI추천

이 간행물의 다른 논문 (5건)